CN Stock MarketDetailed Quotes

300463 Maccura Biotechnology

Watchlist
  • 11.48
  • -0.18-1.54%
Market Closed Sep 13 15:00 CST
7.03BMarket Cap20.72P/E (TTM)

Maccura Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
-7.37%1.28B
-8.88%616.37M
-19.75%2.9B
-22.19%2.12B
-22.51%1.38B
-26.85%676.4M
-9.35%3.61B
-9.67%2.72B
-9.11%1.78B
-13.54%924.73M
Operating revenue
-7.37%1.28B
-8.88%616.37M
-19.75%2.9B
-22.19%2.12B
-22.51%1.38B
-26.85%676.4M
-9.35%3.61B
-9.67%2.72B
-9.11%1.78B
-13.54%924.73M
Other operating revenue
-30.95%12.64M
----
-15.50%33.95M
----
-8.67%18.31M
----
-13.54%40.18M
----
5.01%20.05M
----
Total operating cost
-6.10%1.08B
-9.25%483.29M
-9.30%2.51B
-13.19%1.75B
-11.49%1.15B
-18.55%532.54M
-0.58%2.76B
1.11%2.02B
1.60%1.3B
-1.57%653.86M
Operating cost
-14.57%549.93M
-13.13%262.5M
-21.58%1.3B
-25.72%953.2M
-20.88%643.7M
-28.35%302.17M
-1.32%1.65B
2.34%1.28B
-0.96%813.53M
-0.72%421.71M
Operating tax surcharges
-2.64%11.85M
-10.33%4.03M
-21.40%27.14M
-28.14%17.01M
-30.77%12.17M
-36.51%4.5M
-3.03%34.53M
-6.55%23.67M
0.32%17.58M
-15.91%7.08M
Operating expense
0.41%287.66M
-5.49%120.71M
3.58%652.41M
-0.05%428.47M
1.86%286.48M
-5.50%127.73M
-1.03%629.87M
1.30%428.66M
9.00%281.26M
-5.44%135.17M
Administration expense
11.05%77.03M
-2.63%32.69M
18.27%184.23M
16.35%117.54M
7.12%69.37M
-7.82%33.57M
-7.50%155.77M
2.39%101.02M
2.37%64.76M
2.26%36.42M
Financial expense
-8.73%7.44M
-38.48%3.83M
27.46%23.31M
36.61%16.31M
-49.21%8.15M
-12.27%6.22M
-68.40%18.29M
-72.48%11.94M
-45.39%16.04M
-44.12%7.09M
-Interest expense (Financial expense)
-24.52%11.68M
-2.39%5.95M
-4.34%33.53M
-10.77%24.64M
-18.69%15.47M
-44.57%6.09M
-40.86%35.06M
-39.32%27.62M
-35.19%19.02M
-14.51%10.99M
-Interest Income (Financial expense)
26.70%-3.6M
10.43%-1.84M
16.45%-10.03M
20.64%-7.65M
31.23%-4.91M
59.91%-2.05M
-139.88%-12.01M
-153.26%-9.65M
-175.87%-7.14M
-272.97%-5.11M
Research and development
12.39%144.5M
2.02%59.52M
18.65%324.17M
30.17%217.17M
23.17%128.57M
25.80%58.35M
31.82%273.22M
12.14%166.83M
19.38%104.39M
16.45%46.38M
Credit Impairment Loss
934.00%14.05M
-280.58%-4.86M
-6.38%-36.37M
7.13%-19.07M
86.10%-1.68M
90.36%-1.28M
-254.60%-34.19M
-92.82%-20.54M
-22.82%-12.12M
-9.33%-13.26M
Asset Impairment Loss
93.05%-3.44M
98.15%-93.68K
-142.09%-58.04M
-534.05%-54.33M
-267.39%-49.42M
44.50%-5.06M
-35.95%-23.97M
-31.55%-8.57M
-117.01%-13.45M
-85.96%-9.11M
Other net revenue
153.63%23.53M
194.88%3.36M
-110.55%-58.05M
-222.89%-59.34M
-253.14%-43.87M
82.56%-3.55M
-313.01%-27.57M
-2,625.03%-18.38M
-77.15%-12.42M
-50.59%-20.34M
Fair value change income
74.48%-2.22M
78.08%-1.58M
22.27%-7.08M
-12.66%-15.39M
-856.58%-8.7M
---7.22M
---9.1M
---13.66M
---909.8K
----
Invest income
-66.51%2.65M
-51.15%1.85M
-29.25%8.59M
-21.22%9.92M
30.42%7.9M
--3.79M
2,974.97%12.15M
2,539.81%12.59M
1,274.20%6.06M
----
-Including: Investment income associates
----
--0
-87.86%42.22K
-54.90%202.21K
-10.90%202.21K
--138.32K
-11.92%347.88K
186.87%448.36K
143.97%226.96K
----
Asset deal income
-22.66%-3.43M
-258.71%-1.38M
-1.13%-4.17M
6.14%-3.15M
-0.15%-2.8M
-100.06%-386.04K
-1.74%-4.12M
-185.49%-3.36M
-404.96%-2.79M
74.01%-192.96K
Other revenue
47.10%15.92M
42.86%9.44M
23.17%39.01M
49.69%22.68M
0.36%10.82M
196.88%6.61M
-27.80%31.67M
4.62%15.15M
6.58%10.79M
-47.82%2.23M
Operating profit
18.91%224.04M
-2.75%136.45M
-59.49%331.14M
-55.29%306.05M
-60.07%188.41M
-43.99%140.31M
-32.67%817.39M
-32.68%684.47M
-30.23%471.83M
-36.05%250.53M
Add:Non operating Income
919.61%1.37M
31.79%73.57K
-5.41%378.13K
-4.95%326.02K
196.18%134.75K
420.57%55.82K
-28.51%399.73K
31.02%343.01K
-65.61%45.49K
-76.54%10.72K
Less:Non operating expense
-62.33%2.27M
-89.95%535.22K
-8.91%26.15M
-20.71%10.77M
28.69%6.04M
192.72%5.32M
4.41%28.71M
356.79%13.58M
126.86%4.69M
306.93%1.82M
Total profit
22.26%223.14M
0.70%135.98M
-61.30%305.37M
-55.96%295.6M
-60.93%182.51M
-45.71%135.04M
-33.53%789.08M
-33.80%671.23M
-30.72%467.18M
-36.44%248.72M
Less:Income tax cost
91.53%20.65M
-31.81%11.74M
-99.21%689.9K
-61.09%27.57M
-81.15%10.78M
-52.88%17.22M
-52.74%87.38M
-60.84%70.86M
-51.23%57.2M
-41.02%36.53M
Net profit
17.91%202.49M
5.45%124.24M
-56.58%304.68M
-55.36%268.03M
-58.11%171.73M
-44.47%117.83M
-29.99%701.71M
-27.93%600.37M
-26.40%409.98M
-35.58%212.19M
Net profit from continuing operation
17.91%202.49M
5.45%124.24M
-56.58%304.68M
-55.36%268.03M
-58.11%171.73M
-44.47%117.83M
-29.99%701.71M
-27.93%600.37M
-26.40%409.98M
-35.58%212.19M
Less:Minority Profit
124.57%764.15K
299.05%3.8M
-22.61%-7.94M
-147.77%-645.21K
-173.86%-3.11M
-90.79%952.67K
-114.19%-6.48M
-100.70%-260.41K
-83.41%4.21M
-35.55%10.34M
Net profit of parent company owners
15.38%201.73M
3.05%120.44M
-55.86%312.62M
-55.27%268.68M
-56.91%174.84M
-42.10%116.87M
-25.97%708.18M
-24.56%600.64M
-23.68%405.77M
-35.58%201.84M
Earning per share
Basic earning per share
16.29%0.332
5.26%0.2
-56.20%0.5136
-55.72%0.4387
-57.57%0.2855
-44.10%0.19
-32.25%1.1726
-30.85%0.9907
-29.65%0.6728
-39.77%0.3399
Diluted earning per share
15.38%0.3294
5.26%0.2
-56.19%0.5104
-55.72%0.4387
-57.57%0.2855
-44.10%0.19
-32.18%1.1651
-30.70%0.9907
-29.53%0.6728
-39.58%0.3399
Other composite income
86.27%-1.25M
95.64%-363.65K
-152.74%-8.4M
-215.51%-16.91M
-129.41%-9.12M
-8.33M
472.55%15.93M
14.64M
31.03M
Other composite income of parent company owners
86.27%-1.25M
95.64%-363.65K
-152.74%-8.4M
-215.51%-16.91M
-129.41%-9.12M
---8.33M
472.55%15.93M
--14.64M
--31.03M
----
Total composite income
23.76%201.24M
13.14%123.88M
-58.71%296.28M
-59.17%251.12M
-63.13%162.6M
-48.40%109.49M
-28.09%717.63M
-26.18%615.01M
-20.83%441.01M
-35.58%212.19M
Total composite income of parent company owners
20.98%200.47M
10.63%120.08M
-57.99%304.22M
-59.08%251.77M
-62.06%165.71M
-46.23%108.54M
-23.96%724.11M
-22.72%615.27M
-17.85%436.8M
-35.58%201.84M
Total composite income of minority owners
124.57%764.15K
299.05%3.8M
-22.61%-7.94M
-147.77%-645.21K
-173.86%-3.11M
-90.79%952.67K
-114.19%-6.48M
-100.70%-260.41K
-83.41%4.21M
-35.55%10.34M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue -7.37%1.28B-8.88%616.37M-19.75%2.9B-22.19%2.12B-22.51%1.38B-26.85%676.4M-9.35%3.61B-9.67%2.72B-9.11%1.78B-13.54%924.73M
Operating revenue -7.37%1.28B-8.88%616.37M-19.75%2.9B-22.19%2.12B-22.51%1.38B-26.85%676.4M-9.35%3.61B-9.67%2.72B-9.11%1.78B-13.54%924.73M
Other operating revenue -30.95%12.64M-----15.50%33.95M-----8.67%18.31M-----13.54%40.18M----5.01%20.05M----
Total operating cost -6.10%1.08B-9.25%483.29M-9.30%2.51B-13.19%1.75B-11.49%1.15B-18.55%532.54M-0.58%2.76B1.11%2.02B1.60%1.3B-1.57%653.86M
Operating cost -14.57%549.93M-13.13%262.5M-21.58%1.3B-25.72%953.2M-20.88%643.7M-28.35%302.17M-1.32%1.65B2.34%1.28B-0.96%813.53M-0.72%421.71M
Operating tax surcharges -2.64%11.85M-10.33%4.03M-21.40%27.14M-28.14%17.01M-30.77%12.17M-36.51%4.5M-3.03%34.53M-6.55%23.67M0.32%17.58M-15.91%7.08M
Operating expense 0.41%287.66M-5.49%120.71M3.58%652.41M-0.05%428.47M1.86%286.48M-5.50%127.73M-1.03%629.87M1.30%428.66M9.00%281.26M-5.44%135.17M
Administration expense 11.05%77.03M-2.63%32.69M18.27%184.23M16.35%117.54M7.12%69.37M-7.82%33.57M-7.50%155.77M2.39%101.02M2.37%64.76M2.26%36.42M
Financial expense -8.73%7.44M-38.48%3.83M27.46%23.31M36.61%16.31M-49.21%8.15M-12.27%6.22M-68.40%18.29M-72.48%11.94M-45.39%16.04M-44.12%7.09M
-Interest expense (Financial expense) -24.52%11.68M-2.39%5.95M-4.34%33.53M-10.77%24.64M-18.69%15.47M-44.57%6.09M-40.86%35.06M-39.32%27.62M-35.19%19.02M-14.51%10.99M
-Interest Income (Financial expense) 26.70%-3.6M10.43%-1.84M16.45%-10.03M20.64%-7.65M31.23%-4.91M59.91%-2.05M-139.88%-12.01M-153.26%-9.65M-175.87%-7.14M-272.97%-5.11M
Research and development 12.39%144.5M2.02%59.52M18.65%324.17M30.17%217.17M23.17%128.57M25.80%58.35M31.82%273.22M12.14%166.83M19.38%104.39M16.45%46.38M
Credit Impairment Loss 934.00%14.05M-280.58%-4.86M-6.38%-36.37M7.13%-19.07M86.10%-1.68M90.36%-1.28M-254.60%-34.19M-92.82%-20.54M-22.82%-12.12M-9.33%-13.26M
Asset Impairment Loss 93.05%-3.44M98.15%-93.68K-142.09%-58.04M-534.05%-54.33M-267.39%-49.42M44.50%-5.06M-35.95%-23.97M-31.55%-8.57M-117.01%-13.45M-85.96%-9.11M
Other net revenue 153.63%23.53M194.88%3.36M-110.55%-58.05M-222.89%-59.34M-253.14%-43.87M82.56%-3.55M-313.01%-27.57M-2,625.03%-18.38M-77.15%-12.42M-50.59%-20.34M
Fair value change income 74.48%-2.22M78.08%-1.58M22.27%-7.08M-12.66%-15.39M-856.58%-8.7M---7.22M---9.1M---13.66M---909.8K----
Invest income -66.51%2.65M-51.15%1.85M-29.25%8.59M-21.22%9.92M30.42%7.9M--3.79M2,974.97%12.15M2,539.81%12.59M1,274.20%6.06M----
-Including: Investment income associates ------0-87.86%42.22K-54.90%202.21K-10.90%202.21K--138.32K-11.92%347.88K186.87%448.36K143.97%226.96K----
Asset deal income -22.66%-3.43M-258.71%-1.38M-1.13%-4.17M6.14%-3.15M-0.15%-2.8M-100.06%-386.04K-1.74%-4.12M-185.49%-3.36M-404.96%-2.79M74.01%-192.96K
Other revenue 47.10%15.92M42.86%9.44M23.17%39.01M49.69%22.68M0.36%10.82M196.88%6.61M-27.80%31.67M4.62%15.15M6.58%10.79M-47.82%2.23M
Operating profit 18.91%224.04M-2.75%136.45M-59.49%331.14M-55.29%306.05M-60.07%188.41M-43.99%140.31M-32.67%817.39M-32.68%684.47M-30.23%471.83M-36.05%250.53M
Add:Non operating Income 919.61%1.37M31.79%73.57K-5.41%378.13K-4.95%326.02K196.18%134.75K420.57%55.82K-28.51%399.73K31.02%343.01K-65.61%45.49K-76.54%10.72K
Less:Non operating expense -62.33%2.27M-89.95%535.22K-8.91%26.15M-20.71%10.77M28.69%6.04M192.72%5.32M4.41%28.71M356.79%13.58M126.86%4.69M306.93%1.82M
Total profit 22.26%223.14M0.70%135.98M-61.30%305.37M-55.96%295.6M-60.93%182.51M-45.71%135.04M-33.53%789.08M-33.80%671.23M-30.72%467.18M-36.44%248.72M
Less:Income tax cost 91.53%20.65M-31.81%11.74M-99.21%689.9K-61.09%27.57M-81.15%10.78M-52.88%17.22M-52.74%87.38M-60.84%70.86M-51.23%57.2M-41.02%36.53M
Net profit 17.91%202.49M5.45%124.24M-56.58%304.68M-55.36%268.03M-58.11%171.73M-44.47%117.83M-29.99%701.71M-27.93%600.37M-26.40%409.98M-35.58%212.19M
Net profit from continuing operation 17.91%202.49M5.45%124.24M-56.58%304.68M-55.36%268.03M-58.11%171.73M-44.47%117.83M-29.99%701.71M-27.93%600.37M-26.40%409.98M-35.58%212.19M
Less:Minority Profit 124.57%764.15K299.05%3.8M-22.61%-7.94M-147.77%-645.21K-173.86%-3.11M-90.79%952.67K-114.19%-6.48M-100.70%-260.41K-83.41%4.21M-35.55%10.34M
Net profit of parent company owners 15.38%201.73M3.05%120.44M-55.86%312.62M-55.27%268.68M-56.91%174.84M-42.10%116.87M-25.97%708.18M-24.56%600.64M-23.68%405.77M-35.58%201.84M
Earning per share
Basic earning per share 16.29%0.3325.26%0.2-56.20%0.5136-55.72%0.4387-57.57%0.2855-44.10%0.19-32.25%1.1726-30.85%0.9907-29.65%0.6728-39.77%0.3399
Diluted earning per share 15.38%0.32945.26%0.2-56.19%0.5104-55.72%0.4387-57.57%0.2855-44.10%0.19-32.18%1.1651-30.70%0.9907-29.53%0.6728-39.58%0.3399
Other composite income 86.27%-1.25M95.64%-363.65K-152.74%-8.4M-215.51%-16.91M-129.41%-9.12M-8.33M472.55%15.93M14.64M31.03M
Other composite income of parent company owners 86.27%-1.25M95.64%-363.65K-152.74%-8.4M-215.51%-16.91M-129.41%-9.12M---8.33M472.55%15.93M--14.64M--31.03M----
Total composite income 23.76%201.24M13.14%123.88M-58.71%296.28M-59.17%251.12M-63.13%162.6M-48.40%109.49M-28.09%717.63M-26.18%615.01M-20.83%441.01M-35.58%212.19M
Total composite income of parent company owners 20.98%200.47M10.63%120.08M-57.99%304.22M-59.08%251.77M-62.06%165.71M-46.23%108.54M-23.96%724.11M-22.72%615.27M-17.85%436.8M-35.58%201.84M
Total composite income of minority owners 124.57%764.15K299.05%3.8M-22.61%-7.94M-147.77%-645.21K-173.86%-3.11M-90.79%952.67K-114.19%-6.48M-100.70%-260.41K-83.41%4.21M-35.55%10.34M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data